Back to Search
Start Over
Egret Therapeutics Receives FDA Clearance of IND Application for EGT 101 for Treatment of Delayed Cerebral Ischemia
- Source :
- Plus Company Updates. February 7, 2023
- Publication Year :
- 2023
-
Abstract
- NEW YORK: Turret Capital Management has issued the following news release: Egret Therapeutics, a clinical-stage biotechnology company focused on developing transformative therapies for neurological conditions, today announced that the U.S. [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.737028093